Abiopharma

🔍 Campion Patrick (Executive)

Company: PEAPACK GLADSTONE FINANCIAL CORP (PGC)

Report Date: 2025-03-27

Detailed Transactions and Holdings:

• Sold 340 shares of Common Stock at $28.85 per share (Direct)
  Date: 2025-03-27 | Code: S | equity_swap_involved: false | transaction_form_type: 4
• Acquired 1,675 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 1,675.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,675 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 1,491 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 1,491.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: On March 20, 2025, the reporting person was granted 1,675 restricted stock units (RSUs), vesting on the one year anniversary of the grant. Upon vesting, each RSU converts into one share of PGC common stock.
• F2: On March 20, 2026, the reporting person was granted 1,491 restricted stock units (RSUs), vesting on the one year anniversary of the grant. Upon vesting, each RSU converts into one share of PGC common stock.